Scientific publications

Scientific articles authored by Novo Nordisk

The information you can search here is retrieved via the database Current Contents®, covering 95% of publications within the life science area. Only articles authored by at least one researcher from Novo Nordisk are included in the search results. The database provides easy access to tables of contents, abstracts, bibliographic information, and abstracts from the most recently published issues of leading scholarly journals.

4938 results found.
Showing results 81-100
Journal Author Year
Diabetes Care

Consumption of a Diet Low in Advanced Glycation End Products for 4 Weeks Improves Insulin Sensitivity in Overweight Women

Mark AB ; Poulsen MW ; Andersen S ; Andersen JM ; Bak MJ ; Ritz C ; Holst JJ ; Nielsen J ; de Courten B ; Dragsted LO ; Bugel SG 2014
Diabetes Care

GLP-1 Responses Are Heritable and Blunted in Acquired Obesity With High Liver Fat and Insulin Resistance

Matikainen N ; Bogl LH ; Hakkarainen A ; Lundbom J ; Lundbom N ; Kaprio J ; Rissanen A ; Holst JJ ; Pietilainen KH 2014
Diabetes Care

Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More Than 80,000 People. Diabetes Care 2013; 36: 3411-3417

Khunti K ; Wolden ML ; Thorsted BL ; Andersen M ; Davies MJ 2014
Diabetes Care

Predictive and Explanatory Factors of Change in HbA1c in a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs

Home PD ; Shen CD ; Hasan MI ; Latif ZA ; Chen JW ; Galvez GG 2014
Diabetes Care

Body Composition Is the Main Determinant for the Difference in Type 2 Diabetes Pathophysiology Between Japanese and Caucasians

Moller JB ; Pedersen M ; Tanaka H ; Ohsugi M ; Overgaard RV ; Lynge J ; Almind K ; Vasconcelos NM ; Poulsen P ; Keller C ; Ueki K ; Ingwersen SH ; Pedersen BK ; Kadowaki T 2014
Diabetes Care

GLP-1 Provoked Severe Hypoglycemia in an Individual With Type 2 Diabetes and a Benign Insulinoma

Ruby RJ ; Armato JP ; Pyke C ; Peters AL 2014
Diabetes Care

RESPONSE TO COMMENT ON HOME ET AL. Predictive and Explanatory Factors of Change in HbA(1c) in a 24-Week Observational Study of 66,726 People With Type 2 Diabetes Starting Insulin Analogs. Diabetes Care 2014;37:1237-1245

Home PD ; Shen CD ; Hasan MI ; Latif ZA ; Chen JW ; Galvez GG 2014
Diabetes Care

Comparison of Insulin Degludec/Insulin Aspart and Biphasic Insulin Aspart 30 in Uncontrolled, Insulin-Treated Type 2 Diabetes: A Phase 3a, Randomized, Treat-to-Target Trial

Fulcher GR ; Christiansen JS ; Bantwal G ; Polaszewska-Muszynska M ; Mersebach H ; Andersen TH ; Niskanen LK 2014
Diabetes Care

Personal Accounts of the Negative and Adaptive Psychosocial Experiences of People With Diabetes in the Second Diabetes Attitudes, Wishes and Needs (DAWN2) Study

Stuckey HL ; Mullan-Jensen CB ; Reach G ; Burns KK ; Piana N ; Vallis M ; Wens J ; Willaing I ; Skovlund SE ; Peyrot M 2014
Diabetes Care

Effect of Early Multifactorial Therapy Compared With Routine Care on Microvascular Outcomes at 5 Years in People With Screen-Detected Diabetes: A Randomized Controlled Trial The ADDITION-Europe Study

Sandbaek A ; Griffin SJ ; Sharp SJ ; Simmons RK ; Borch-Johnsen K ; Rutten GEHM ; van den Donk M ; Wareham NJ ; Lauritzen T ; Davies MJ ; Khunti K 2014
Diabetes Care

Insulin Sensitivity and Albuminuria: The RISC Study

Pilz S ; Rutters F ; Nijpels G ; Stehouwer CDA ; Hojlund K ; Nolan JJ ; Balkau B ; Dekker JM 2014
Diabetes Care

Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors

Andresdottir G ; Jensen ML ; Carstensen B ; Parving HH ; Rossing K ; Hansen TW ; Rossing P 2014
Diabetes Obesity and Metabolism

A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)

Mathieu C ; Rodbard HW ; Cariou B ; Handelsman Y ; Philis-Tsimikas A ; Francisco AMO ; Rana A ; Zinman B 2014
Diabetes Obesity and Metabolism

Improved real-world glycaemic outcomes with liraglutide versus other incretin-based therapies in type 2 diabetes

Lee WC ; Dekoven M ; Bouchard J ; Massoudi M ; Langer J 2014
Diabetes Obesity and Metabolism

Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naive patients with type 2 diabetes

Rodbard HW ; Cariou B ; Zinman B ; Handelsman Y ; Wolden ML ; Rana A ; Mathieu C 2014
Diabetes Obesity and Metabolism

Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin - from the UK health care cost perspective

Evans M ; Wolden M ; Gundgaard J ; Chubb B ; Christensen T 2014
Diabetes Obesity and Metabolism

A prospective, claims-based assessment of the risk of pancreatitis and pancreatic cancer with liraglutide compared to other antidiabetic drugs

Funch D ; Gydesen H ; Tornoe K ; Major-Pedersen A ; Chan KA 2014
Diabetes Obesity and Metabolism

A randomized controlled trial of the efficacy and safety of saxagliptin as add-on therapy in patients with type 2 diabetes and inadequate glycaemic control on metformin plus a sulphonylurea

Toreov SS ; Holst JJ ; Ehlers MR 2014
Diabetes Obesity and Metabolism

Weight change upon once-daily initiation of insulin detemir with or without dietary intervention in overweight or obese insulin-naive individuals with type 2 diabetes: results from the DIET trial

Niswender K ; Piletic M ; Andersen H ; Hiort LC ; Hollander P 2014
Diabetes Research and Clinical Practice

Glycaemic threshold for diabetes-specific retinopathy among individuals from Saudi Arabia, Algeria and Portugal

Almdal TP ; Handlos LN ; Valerius M ; Juul E ; Nielsen KE ; Vistisen D ; Nielsen LB ; Sheikh A ; Belhadj M ; Nadir D ; Zinai S ; Raposo J ; Lund-Andersen H ; Witte DR 2014